Some of the commentary I see is typical OTC banter of persuasion. People should simply ask themselves do they believe that all these stakeholders, all these collaborators, all these efforts to develop serious drug candidates in their pipeline is going to be put at risk because of some OTC shenanagins?
Come on.
Premier medical institutions, premier consulting organizations, DOD funding, working with the NIH.... The executives here have a fiduciary duty to this company and all the stakeholders simple as that and cannot allow these assets and their development to be put at risk too much longer because of failure in this aspect of the company.